Know Cancer

or
forgot password


Phase 3
N/A
N/A
Not Enrolling
Both
Glioblastoma

Thank you

Trial Information


Inclusion Criteria:



- Patients with Newly Diagnosed Glioblastoma

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

safety and efficacy

Outcome Time Frame:

5 years

Safety Issue:

No

Principal Investigator

Naseer Al-Rajhi

Investigator Role:

Principal Investigator

Investigator Affiliation:

KFSH & RC

Authority:

United States: Institutional Review Board

Study ID:

RAC#2081-018

NCT ID:

NCT01364064

Start Date:

January 2007

Completion Date:

June 2009

Related Keywords:

  • Glioblastoma
  • Glioblastoma

Name

Location